Computational Biology

Computational Biology Market (Pharmacodynamics, Cellular Modeling, Computational Genomics, Proteomics, Pharmacogenomics, Pharmacokinetics, Human Simulation Software, Drug Discovery & Development) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2012 - 2018

  • Rep Id : TMRGL1120
  • Published On : May 2013
  • No. of Pages : 112
  • Category : Healthcare

Table of Content
 
Chapter 1 Introduction
1.1 Report Description
1.2 Market Segmentation
1.3 Scope Of The Report
1.4 Research Methodology
      1.4.1 Sources
               1.4.1.1 Secondary Research
               1.4.1.2 Primary Research
               1.4.1.3 Models
1.5 Assumptions
 
Chapter 2 Executive Summary
2.1 Market Snapshot: Global Computational Biology Market (2011 & 2018)
2.2 Global Computational Biology Market, by Types, 2011 (USD Million)
 
Chapter 3 Global Computational Biology Market Dynamics
3.1 Market Overview
3.2 Drivers
      3.2.1 Failure Of Drug Candidates in Late Stage of Clinical Trials
               3.2.1.1 Average Cost to Develop One New Drug (1975 -2011) (USD Million)
               3.2.1.2 Trend of Rise in Failure of Phase II Clinical Trials (2006- 2012)
               3.2.1.3 Reasons For Failure (%) in Phase II & Phase III
      3.2.2 Enhanced Computational Tools
      3.2.3 Improved Government Funding &Industrial Support
3.3 Restraints
      3.3.1 Lack of Standardization
      3.3.2 Non-Verified Predictive Models
3.4 Challenges
      3.4.1 Shortage of Skilled Resources
      3.4.2 Data Storage
3.5 Opportunities
      3.5.1 Cloud Computing
      3.5.2 Modelling And Simulations in Paediatrics Drug Development
3.6 Porters Five Forces Analysis
      3.6.1 Bargaining Power of Suppliers
      3.6.2 Bargaining Power of Buyers
      3.6.3 Threat of New Entrants
      3.6.4 Threat Of Substitutes
      3.6.5 Competitive Rivalry
3.7 Market Attractiveness Analysis
      3.7.1 Market Attractiveness Analysis: Global Computational Biology Market, by Geography
3.8 End User Analysis
      3.8.1 End User Analysis: Global Computational Biology Market, 2011 & 2018 (%)
 
Chapter 4 Global Computational Biology Market, by Applications
4.1 Introduction
      4.1.1 Cellular Modelling and Simulation
               4.1.1.1 Computational Genomics
                          4.1.1.1.1 Global Computational Genomics Market Revenues, 2010 – 2018 (USD Million)
               4.1.1.2 Computational Proteomics
                          4.1.1.2.1 Global Computational Proteomics Market Revenues, 2010 – 2018 (USD Million)
               4.1.1.3 Pharmacogenomics
                          4.1.1.3.1 Global Computational Pharmacogenomics Market Revenues, 2010 – 2018 (USD Million)
               4.1.1.4 Others (Metabolomics/ Transcriptomics)
                          4.1.1.4.1 Global Computational Others (Metabolomics/Transcriptomics) Market Revenue, 2010 – 2018 (USD Million)
      4.1.2 Disease Modelling And Simulation Applications / CADD (Computer Aided Drug Design)
              4.1.2.1 Drug Discovery
                         4.1.2.1.1 Global Computational Drug Discovery Market Revenues, 2010 – 2018 (USD Million)
                         4.1.2.1.2 Target Identification
                                       4.1.2.1.2.1 Global Computational Target Identification Market Revenues, 2010 – 2018 (USD Million)
                         4.1.2.1.3 Target Validation
                                       4.1.2.1.3.1 Global Computational Target Validation Market Revenues, 2010 – 2018 (USD Million)
                         4.1.2.1.4 Lead Identification/Discovery
                                       4.1.2.1.4.1 Global Computational Lead Identification Market Revenues, 2010 – 2018 (USD Million)
                         4.1.2.1.5 Lead Optimization
                                       4.1.2.1.5.1 Global Computational Lead Optimization Market Revenues, 2010 – 2018 (USD Million)
             4.1.2.1 Drug Development
                         4.1.2.1.1 Preclinical
                                       4.1.2.1.1.1 Global Computational Preclinical Trials Market Revenues, 2010 – 2018 (USD Million)
                         4.1.2.1.2 Clinical Trials
                                       4.1.2.1.2.1 Global Computational Clinical Trials Market Revenues, 2010 – 2018 (USD Million)
                                       4.1.2.1.2.2 Phase I
                                       4.1.2.1.2.3 Global Computational Clinical Trials Phase I Market Revenues, 2010 – 2018 (USD Million)
                                       4.1.2.1.2.4 Phase II
                                       4.1.2.1.2.5 Global Computational Clinical Trials Phase II Market Revenues, 2010 – 2018 (USD Million)
                                       4.1.2.1.2.6 Phase III
                                       4.1.2.1.2.7 Global Computational Clinical Trials Phase III Market Revenues, 2010 – 2018 (USD Million)
                         4.1.2.1.3 Human Body Simulation Software
                                       4.1.2.1.3.1 Global Computational Human Simulation Software Market Revenues, 2010 – 2018 (USD Million)
 
Chapter 5 Global Computational Biology Market, by Tools
5.1 Overview
5.2 Database
      5.2.1 Global Computational Biology Database Market Revenues, 2010 – 2018 (USD Million)
5.3 IT Infrastructure (Hardware)
      5.3.1 Global Computational Biology Hardware Market Revenues, 2010 – 2018 (USD Million)
5.4 Analysis Software & Services
      5.4.1 Global Computational Biology Software Market Revenues, 2010 – 2018 (USD Million)
 
Chapter 6 Global Computational Biology Market, by Services
6.1 Overview
6.2 In-House Computational Biology
      6.2.1 Global In-House Computational Biology Market Revenues, 2010 – 2018 (USD Million)
6.3 External/Contract Computational Biology
      6.3.1 Global Contract Computational Biology Market Revenues, 2010 – 2018 (USD Million)
 
Chapter 7 Global Computational Biology Market, by Geography
7.1 Overview
7.2 North America
      7.2.1 North America Computational Biology Market Revenues, 2010 – 2018 (USD Million)
7.3 Europe
      7.3.1 Europe Computational Biology Market Revenues, 2010 – 2018 (USD Million)
7.4 Asia
      7.4.1 Asia Computational Biology Market Revenues, 2010 – 2018 (USD Million)
7.5 ROW
      7.5.1 Row Computational Biology Market Revenues, 2010 – 2018 (USD Million)
 
Chapter 8 Market Share Analysis
8.1 Market Share by Key Players
      8.1.1 Global Computational Biology Market Share Analysis of Key Players, 2011 (%)
 
Chapter 9 Recommendations
9.1 Success Strategies
      9.1.1 Rigorous Research and Development (R&D) Initiatives
      9.1.2 Investing in Emerging Economies
      9.1.3 Investing in High-End Technologies
      9.1.4 Collaborations, Mergers and Acquisitions
9.2 Barriers to be Considered
      9.2.1 High Cost of Investment
 
Chapter 10 Company Profiles
10.1 Accelrys
      10.1.1 Company Overview
      10.1.2 Financial Overview
      10.1.3 Product Portfolio And Services
      10.1.4 Business Strategy
      10.1.5 Recent Developments
10.2 Certara
      10.2.1 Company Profile
      10.2.2 Financial Overview
      10.2.3 Product Portfolio And Services
      10.2.4 Business Strategy
      10.2.5 Recent Developments
10.3 Chemical Computing Group Inc.
      10.3.1 Company Profile
      10.3.2 Financial Overview
      10.3.3 Product Portfolio
      10.3.4 Business Strategy
      10.3.5 Recent Developments
10.4 Compugen, Ltd
      10.4.1 Company Profile
      10.4.2 Financial Overview
      10.4.3 Business Strategy
      10.4.4 Recent Developments
10.5 Entelos
      10.5.1 Company Profile
      10.5.2 Financial Overview
      10.5.3 Product Portfolio And Services
      10.5.4 Business Strategy
      10.5.5 Recent Developments
10.6 Genedata AG
      10.6.1 Company Profile
      10.6.2 Financial Overview
      10.6.3 Product Portfolio And Services
      10.6.4 Business Strategy
      10.6.5 Recent Developments
10.7 Insilico Biotechnology AG
      10.7.1 Company Profile
      10.7.2 Financial Overview
      10.7.3 Product Portfolio
      10.7.4 Business Strategy
      10.7.5 Recent Developments
10.8 Leadscope, Inc
      10.8.1 Company Profile
      10.8.2 Financial  Overview
      10.8.3 Product Portfolio
      10.8.4 Business Strategy
      10.8.5 Recent Developments
10.9 Nimbus Discovery LLC
      10.9.1 Company Profile
      10.9.2 Financial Overview
      10.9.3 Product Portfolio
      10.9.4 Business Strategy
      10.9.5 Recent Developments
10.10 Rhenovia  Pharma SAS
      10.10.1 Company Profile
      10.10.2 Financial Overview
      10.10.3 Product Portfolio And Services
      10.10.4 Business Startegy
      10.10.5 Recent Developments
10.11 Schrodinger
      10.11.1 Company Overview
      10.11.2 Financial Overview
      10.11.3 Product Portfolio And Services
      10.11.4 Business Strategy
      10.11.5 Recent Developments
10.12 Simulation Plus, Inc.
      10.12.1 Company Profile
      10.12.2 Financial Overview
      10.12.3 Product Portfolio And Services
      10.12.4 Business Strategy
      10.12.5 Recent Developments

List of Tables
 
TABLE 1 Global Computational Biology Market: Snapshot (2011 & 2018)
TABLE 2 R&D Function by Expenditure (%)
TABLE 3 Global Computational Biology Market Revenues, by Segments, 2010 – 2018 (USD Million)
TABLE 4 Global Cellular Modeling and Biology Simulation Market Revenues, by Types, 2010 – 2018 (USD Million)
TABLE 5 Global Cellular Modeling and Biology Simulation Market Revenues, by Geography, 2010 – 2018 (USD Million)
TABLE 6 Global Disease Modeling and Simulation Market Revenues, by Types, 2010 - 2018 (USD Million)
TABLE 7 Global Disease Modeling and Simulation Market Revenues, by Geography, 2010 - 2018 (USD Million)
TABLE 8 Global Computational Drug Development Market Revenues, by Types, 2010 - 2018 (USD Million)
TABLE 9 Software Packages for PBPK Modeling
TABLE 10 Global Computational Biology Market Revenues, by Tools, 2010- 2018 (USD Million)
TABLE 11 Global Computational Services Market Revenues, by Services, 2010- 2018 (USD Million)
TABLE 12 Global Computational Biology Market, by Geography, 2010- 2018 (USD Million)

List of Figures
 
FIG. 1 Global Computational Biology: Market Segmentation
FIG. 2 Global Computational Biology Market, By Types, 2011 (USD Million)
FIG. 3 Average Cost to Develop one New Drug (1975 -2011) (USD Million)
FIG. 4 Trend of Rise in Failure of Phase II Clinical Trials (2006- 2012)
FIG. 5 Reasons for Failure (%) in Phase II & Phase III
FIG. 6 Porter’s Five Forces Analysis for Computational Biology Market
FIG. 7 Market Attractiveness Analysis: Global Computational Biology Market, By Geography
FIG. 8 End User Analysis: Global Computational Biology Market, 2011 & 2018 (%)
FIG. 9 Global Computational Genomics Market Revenues, 2010 – 2018 (USD Million)
FIG. 10 Global Computational Proteomics Market Revenues, 2010 – 2018 (USD Million)
FIG. 11 Global Computational Pharmacogenomics Market Revenues, 2010 – 2018 (USD Million)
FIG. 12 Global Computational Others (Metabolomics/ Transcriptomics) Market Revenue, 2010 – 2018 (USD Million)
FIG. 13 Global Computational Drug Discovery Market Revenues, 2010 – 2018 (USD Million)
FIG. 14 Global Computational Target Identification Market Revenues, 2010 – 2018 (USD Million)
FIG. 15 Global Computational Target Validation Market Revenues, 2010 – 2018 (USD Million)
FIG. 16 Global Computational Lead Identification Market Revenues, 2010 – 2018 (USD Million)
FIG. 17 Global Computational Lead Optimization Market Revenues, 2010 – 2018 (USD Million)
FIG. 18 Global Computational Preclinical Trials Market Revenues, 2010 – 2018 (USD Million)
FIG. 19 Global Computational Clinical Trials Market Revenues, 2010 – 2018 (USD Million)
FIG. 20 Global Computational Clinical Trials Phase I Market Revenues, 2010 – 2018 (USD Million)
FIG. 21 Global Computational Clinical Trials Phase II Market Revenues, 2010 – 2018 (USD Million)
FIG. 22 Global Computational Clinical Trials Phase III Market Revenues, 2010 – 2018 (USD Million)
FIG. 23 Global Computational Human Simulation Software Market Revenues, 2010 – 2012 (USD Million)
FIG. 24 Global Computational Biology Database Market Revenues, 2010 – 2018 (USD Million)
FIG. 25 Global Computational Biology Hardware Market Revenues, 2010 – 2018 (USD Million)
FIG. 26 Global Computational Biology Software Market Revenues, 2010 – 2018 (USD Million)
FIG. 27 Global In-House Computational Biology Market Revenues, 2010 – 2018 (USD Million)
FIG. 28 Global Contract Computational Biology Market Revenues, 2010 – 2018 (USD Million)
FIG. 29 North America Computational Biology Market Revenues, 2010 – 2018 (USD Million)
FIG. 30 Europe Computational Biology Market Revenues, 2010 – 2018 (USD Million)
FIG. 31 Asia Computational Biology Market Revenue, 2010 – 2018 (USD Million)
FIG. 32 Row Computational Biology Market Revenues, 2010 – 2018 (USD Million)
FIG. 33 Global Computational Biology Market Share Analysis Of Key Players, 2011 (%)
FIG. 34 Annual Revenues: Accelrys, 2009 - 2011 (USD Million)
FIG. 35 Annual Revenue: Compugen, 2010 – 2012 (USD Million)
FIG. 36 Annual Revenues: Simulation Plus, Inc., 2010 – 2012 (USD Million)